Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systemmatic literature review on indirect costs of women with breast cancer
Saeed Mohammadpour, Samira Soleimanpour, Javad Javan‐Noughabi, et al.
Cost Effectiveness and Resource Allocation (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Productivity Losses due to Health Problems Arising from COVID-19 Pandemic: A Systematic Review of Population-Level Studies Worldwide
Paweł Niewiadomski, Marta Ortega‐Ortega, Błażej Łyszczarz
Applied Health Economics and Health Policy (2025)
Closed Access | Times Cited: 1
Gender bias in health financing methods: metrics and data
Kalipso Chalkidou, Richard Sullivan
BMJ Global Health (2025) Vol. 10, Iss. 3, pp. e016746-e016746
Open Access
Antitumor efficacy of silver nanoparticles reduced with β-D-glucose as neoadjuvant therapy to prevent tumor relapse in a mouse model of breast cancer
Moisés Ármides Franco-Molina, David Reding Hernández, Paola Leonor García Coronado, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 1
Estimating the indirect economic burden of cancer in Jordan: a retrospective observational study
Omar Rashdan
BMJ Open (2024) Vol. 14, Iss. 6, pp. e082025-e082025
Open Access | Times Cited: 1
Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review
Matthew Franklin, Daniel Pollard, Janvi Sah, et al.
Advances in Therapy (2024) Vol. 41, Iss. 7, pp. 2700-2722
Open Access | Times Cited: 1
A Narrative Review of the Clinical, Humanistic, and Economic Value of Pembrolizumab-Based Immunotherapy for the Treatment of Breast and Gynecologic Cancers
Matthew Monberg, Steve Keefe, Vassiliki Karantza, et al.
Oncology and Therapy (2024)
Open Access | Times Cited: 1
Productivity losses from short-term work absence due to neoplasms in Poland
Błażej Łyszczarz
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Estimating Public Economic Gains from Early Breast Cancer and Curative Treatment: A Case Study in Human Epidermal Growth Factor Receptor (HER-2) Positive Targeted Therapies
Svenn Alexander Kommandantvold, Nikolaos Kotsopoulos, Isabel Monteiro, et al.
Oncology and Therapy (2024) Vol. 12, Iss. 2, pp. 277-292
Open Access
Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system
S Fénix-Caballero, Adrián Sánchez-Vegas, Emilio Jesús Alegre Del Rey, et al.
The European Journal of Health Economics (2024)
Closed Access
Breast Cancer and Income Loss in Denmark: Heterogeneous Outcomes and Longitudinal Effects
Emily Johnson, Harsh Parikh, Kim Rose Olsen, et al.
Research Square (Research Square) (2024)
Closed Access
Economic Burden of Cancer for the First Five Years after Cancer Diagnosis in Patients with Human Immunodeficiency Virus in Korea
Yoonyoung Jang, Taehwa Kim, Brian H. S. Kim, et al.
Journal of Cancer Prevention (2023) Vol. 28, Iss. 2, pp. 53-63
Open Access
Page 1

Scroll to top